What Verdica's 799 score means for BRAEBURN
BRAEBURN's composite score of 799 out of 850 places the pharmacy provider in the "strong" band (740–799), indicating reliable compliance performance across the regulatory dimensions Verdica tracks. A score in this range reflects a provider that meets core licensing and operational standards with minimal red flags in state board records, FDA oversight, or DEA tracking.
Readers should interpret this as a provider with a solid regulatory foundation. The 799 score does not indicate perfection—that would require an 800+ rating in the "excellent" band—but it does signal that BRAEBURN has demonstrated sustained adherence to pharmacy regulations as measured by the underlying regulator databases. For a business owner or consumer evaluating pharmacy providers, this score suggests a reasonable baseline of compliance, though the specific sub-score breakdown below offers more granular insight into where strengths and potential gaps exist.
No independent customer reviews are currently indexed for BRAEBURN on Verdica's platform, so this analysis is based entirely on regulatory data rather than user experience feedback.
How the sub-scores break down
Product Approval (850/850): This perfect sub-score indicates that BRAEBURN's product portfolio—whether sourced, manufactured, or distributed—aligns with FDA approval requirements. In plain terms, the medications, devices, or compounds associated with this provider have cleared the necessary regulatory pathways. A high score here typically means no flagged products, recalls specific to this entity's handling, or unapproved therapeutic claims in regulatory records.
Manufacturer Profile (720/850): This sub-score sits in the "acceptable" range and is the lowest of the three dimensions. A manufacturer profile score reflects data on production standards, facility inspections, quality control documentation, and any observations logged by FDA or state inspectors. A 720 suggests that BRAEBURN's manufacturing or sourcing practices meet baseline requirements, but may include minor observations, older inspection findings, or areas where regulatory bodies noted room for improvement. This is not uncommon for established providers and does not necessarily indicate a safety or quality crisis.
FDA Compliance (830/850): This strong sub-score reflects BRAEBURN's adherence to federal drug and pharmacy regulations as tracked through FDA databases. It suggests minimal violations or warning letters on record and general alignment with labeling, reporting, and distribution standards. An 830 indicates solid compliance posture, though the 20-point gap from perfect suggests at least minor historical observations or compliance notes that have not materially escalated.
What regulators track for pharmacy providers
State boards of pharmacy maintain licensure records, disciplinary histories, and facility inspection logs for all operating pharmacies and pharmacy providers. Regulators flag issues such as improper storage conditions, inaccurate record-keeping, unauthorized practice, or staffing violations. These records directly influence Verdica's scoring.
The FDA oversees drug approval, manufacturing standards, and facility compliance. Agency inspections can result in observations, warning letters, or import alerts if systemic issues are identified. The FDA also tracks product recalls, adverse event reports, and labeling compliance.
The DEA regulates controlled substances, including dispensing records, security protocols, and inventory management. Discrepancies in controlled substance accounting, suspicious ordering patterns, or diversion-related incidents are documented in DEA systems.
Together, these three data sources create a regulatory compliance profile. Providers with clean records, no recent disciplinary actions, and successful inspections score higher. Those with unresolved violations, repeated observations across inspections, or pattern-based concerns score lower.
Bottom line
BRAEBURN's 799 score reflects a provider with strong regulatory compliance grounded in solid FDA adherence and perfect product approval status. The manufacturer profile sub-score suggests room for minor improvement in production or sourcing practices. For those considering a relationship with BRAEBURN, the strong composite score warrants confidence, though direct verification of current licensing status and any recent state board communications remains prudent due diligence.